相关实验视频
Updated: Jan 10, 2026

04:16
Whole Body Vibration Methods with Survivors of Polio
Published on: October 17, 2018
9.2K
关于帕金森病症状的多会期全身振动计划:系统性审查和元分析
Paula González-García1, Alberto Marcos Heredia-Rizo2, Alfonso Garrido-Bueno3
1Physiotherapy Department, Faculty of Nursing, Physiotherapy and Podiatry, University of Seville, Seville, Spain; Instituto de Biomedicina de Sevilla, IBiS, Departamento de Fisioterapia, Universidad de Sevilla, Spain.
Journal of bodywork and movement therapies
|November 29, 2025
概括
全身振动 (WBV) 可能改善帕金森病 (PD) 患者的静态平衡. 然而,在本次审查中,WBV并没有显著改善其他运动症状,步态或功能移动性.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 运动障碍 运动障碍
背景情况:
- 帕金森病 (PD) 是一种进展性神经退行性疾病,其全球流行率正在增加.
- 患PD显著损害患者的生活质量和功能独立性.
- 目前的治疗策略旨在控制症状并保持患者的功能.
研究的目的:
- 系统地审查和元分析全身振动 (WBV) 干预措施对各种帕金森病症状的影响.
- 评估WBV对PD患者的运动功能,步态,平衡和整体生活质量的影响.
- 评估PD管理中WBV的方法质量和证据的确定性.
主要方法:
- 在主要数据库 (PubMed,CINHAL,EMBASE,Cochrane图书馆) 进行了系统的文献搜索.
- 包括针对帕金森病症状的WBV干预 (多次会议) 的随机临床试验 (RCT).
- 使用柯克兰偏差风险工具-2评估研究质量,使用GRADE评估证据确定性,使用TIDieR评估可复制性;进行了元分析.
主要成果:
- 六项研究符合纳入标准,显示出高可重复性 (TIDieR分数).
- 与主动对照相比,WBV干预显示出静态平衡的显著改善.
- 在WBV和对照组之间,没有观察到步行速度,功能移动性或其他运动症状的显著差异.
- 在各个研究中都注意到对偏差风险和证据确定性低的高度担忧.
结论:
- 全身振动对帕金森病患者的静态平衡有潜在的益处.
- 然而,WBV在其他关键运动症状,步态或功能性移动性方面没有表现出优于对照者的效果.
- 由于研究有限和方法方面的担忧,目前无法对PD中WBV做出确切的临床建议.
相关概念视频
Parkinson's Disease: Treatment
945
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
945
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K

